Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

Article  CAS  PubMed  Google Scholar 

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB. Virus taxonomy: the database of the international committee on taxonomy of viruses (ICTV). Nucleic Acids Res. 2018;46(D1):D708–17.

Article  CAS  PubMed  Google Scholar 

King AM, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy. Ninth report of the International Committee on Taxonomy of Viruses 2012;770–783.

Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020;21(1):224.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalakas MC, Bitzogli K, Alexopoulos H. Anti-SARS-CoV-2 antibodies within IVIg preparations: cross-reactivities with seasonal coronaviruses, natural autoimmunity, and therapeutic implications. Front Immunol. 2021;12: 627285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muccioli L, Pensato U, Bernabe G, Ferri L, Tappata M, Volpi L, Cani I, Henry OJ, Ceccaroni F, Cevoli S, et al. Intravenous immunoglobulin therapy in COVID-19-related encephalopathy. J Neurol. 2020;268(8):2671–5.

Article  PubMed  PubMed Central  Google Scholar 

Gharebaghi N, Nejadrahim R, Mousavi SJ, Sadat-Ebrahimi SR, Hajizadeh R. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis. 2020;20(1):786.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao W, Liu X, Bai T, Fan H, Hong K, Song H, Han Y, Lin L, Ruan L, Li T. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open Forum Infect Dis. 2020;7(3):ofaa102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galeotti C, Kaveri SV, Bayry J. Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19). Clin Transl Immunol. 2020;9(10): e1198.

Article  CAS  Google Scholar 

Diez JM, Romero C, Gajardo R. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens. Immunotherapy. 2020;12(8):571–6.

Article  CAS  PubMed  Google Scholar 

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.

CAS  PubMed  PubMed Central  Google Scholar 

Kimura R, Yoda A, Hayashizaki Y, Chiba J. Novel ELISA using intracellularly biotinylated antigen for detection of antibody following DNA immunization. Jpn J Infect Dis. 2010;63(1):41–8.

Article  CAS  PubMed  Google Scholar 

Daneshpazhooh M, Soori T, Isazade A, Noormohammadpour P. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. J Dermatol Treat. 2020. https://doi.org/10.1080/09546634.2020.1764472.

Article  Google Scholar 

Shao Z, Feng Y, Zhong L, Xie Q, Lei M, Liu Z, Wang C, Ji J, Liu H, Gu Z, et al. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study. Clin Trans Immunol. 2020;9(10): e1192.

Article  CAS  Google Scholar 

Cao W, Liu X, Hong K, Ma Z, Zhang Y, Lin L, Han Y, Xiong Y, Liu Z, Ruan L, et al. High-dose intravenous immunoglobulin in severe coronavirus disease 2019: a multicenter retrospective study in China. Front Immunol. 2021;12: 627844.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–62.

Article  PubMed  Google Scholar 

Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Undurraga EA, Chowell G, Mizumoto K. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020. Infect Dis Poverty. 2021;10(1):11.

Article  PubMed  PubMed Central  Google Scholar 

Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1):1742.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crimmins EM. Age-related vulnerability to coronavirus disease 2019 (COVID-19): biological, contextual, and policy-related factors. Public Policy Aging Rep. 2020;30(4):142–6.

Article  PubMed  PubMed Central  Google Scholar 

Abbasi J. COVID-19 and the common cold-preexisting coronavirus antibodies may hinder SARS-CoV-2 immunity. JAMA. 2022;327(7):609–10.

Article  CAS  PubMed  Google Scholar 

Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, Burger ZC, Rawlings SA, Smith DM, Phillips E, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370(6512):89–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Zarka J, Moneger G, Santoli F, Argaud L, et al. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):158–66.

Article  CAS  PubMed  Google Scholar 

Chen Y, Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang Y, Huang T, Zheng K, et al. Intravenous immunoglobulin therapy for critically Ill COVID-19 patients with different inflammatory phenotypes: a multicenter, retrospective study. Front Immunol. 2021;12: 738532.

Article  CAS  PubMed  Google Scholar 

Mercurio I, Tragni V, Busto F, De Grassi A, Pierri CL: Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Cellular and molecular life sciences : CMLS 2020.

Schwaiger J, Karbiener M, Aberham C, Farcet MR, Kreil TR. No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic. J Infect Dis. 2020;222(12):1960–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;73(11):e4208–e4213.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30211-7.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Li Q, Zheng D, Jiang H, Wei Y, Zou L, Feng L, Xiong G, Sun G, Wang H, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. New England J Med. 2020;382(25):e100.

Article  CAS  Google Scholar 

Henry BM, Vikse J. Clinical characteristics of Covid-19 in China. New Engl J Med. 2020;382(19):1860–1.

PubMed  Google Scholar